Vident Investment Advisory, LLC Gracell Biotechnologies Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$2.08 - $5.15 $6,822 - $16,892
-3,280 Reduced 16.43%
16,681 $54,000
Q1 2022

May 16, 2022
BUY
$1.83 - $5.52 $13,415 - $40,467
7,331 Added 58.04%
19,961 $47,000
Q4 2021

Feb 14, 2022
SELL
$5.65 - $14.9 $21,684 - $57,186
-3,838 Reduced 23.31%
12,630 $76,000
Q3 2021

Nov 12, 2021
BUY
$9.91 - $14.84 $163,197 - $244,385
16,468 New
16,468 $228,000

Others Institutions Holding GRCL

# of Institutions
2
Shares Held
75.1K
Call Options Held
0
Put Options Held
0
View Full List

About Gracell Biotechnologies Inc.

GRCL Quotes by TradingView
  • Ticker GRCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,674,096
  • Description
  • Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...
More about GRCL
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email